News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Barrett Elizabeth A.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| Barrett Elizabeth A. (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 116,120 options to buy
@ $5.7, valued at
$661.9k
|
|
| 02/02/2023 |
4
| Barrett Elizabeth A. (CEO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 5,000 restricted stock units
@ $0
Exercised 13,333 restricted stock units
@ $0
Granted 75,000 restricted stock units
@ $0
Granted 125,000 options to buy
@ $10.39, valued at
$1.3M
Granted 100,000 rights
@ $0 |
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Barrett Elizabeth A. (CEO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 2,235 shares
@ $7.58, valued at
$16.9k
Sold 5,960 shares
@ $7.58, valued at
$45.2k
Exercised 5,000 restricted stock units
@ $0
Exercised 13,333 restricted stock units
@ $0
Granted 150,000 options to buy
@ $7.72, valued at
$1.2M
|
|
| 01/07/2022 |
4
| Barrett Elizabeth A. (CEO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 46,968 shares
@ $9.15, valued at
$429.8k
Exercised 105,689 restricted stock units
@ $0 |
|
| 08/03/2021 |
4
| Barrett Elizabeth A. (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 63,385 options to buy
@ $21.95, valued at
$1.4M
|
|
| 08/03/2021 |
3
| Barrett Elizabeth A. (Director) has filed a Form 3 on Allogene Therapeutics, Inc. |
| 07/12/2021 |
4/A
| Barrett Elizabeth A. (CEO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 8,807 restricted stock units
@ $0
Exercised 8,807 restricted stock units
@ $0
Exercised 8,807 restricted stock units
@ $0
Exercised 8,807 restricted stock units
@ $0
Exercised 8,808 restricted stock units
@ $0
Exercised 8,808 restricted stock units
@ $0
Exercised 8,808 restricted stock units
@ $0 |
|
| 07/12/2021 |
4/A
| Barrett Elizabeth A. (CEO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 8,807 restricted stock units
@ $0
Exercised 8,807 restricted stock units
@ $0
Exercised 8,807 restricted stock units
@ $0
Exercised 8,808 restricted stock units
@ $0 |
|
| 05/21/2021 |
4
| Barrett Elizabeth A. (CEO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Paid exercise price by delivering 2,185 shares
@ $17.5089, valued at
$38.3k
Paid exercise price by delivering 1,240 shares
@ $17.5089, valued at
$21.7k
Exercised 8,807 restricted stock units
@ $0
Exercised 5,000 restricted stock units
@ $0 |
|
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
4
| Barrett Elizabeth A. (CEO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Bought 10,000 shares
@ $18.5, valued at
$185k
|
|
| 12/04/2020 |
4
| Barrett Elizabeth A. (CEO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 61,652 restricted stock units
@ $0 |
|
| 11/20/2020 |
3
| Barrett Elizabeth A. (Director) has filed a Form 3 on Lifesci Acquisition II Corp. |
| 05/14/2020 |
4
| Barrett Elizabeth A. (CEO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 35,229 restricted stock units
@ $0 |
|
| 02/04/2020 |
4
| Barrett Elizabeth A. (CEO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 45,000 options to buy
@ $29.41, valued at
$1.3M
Granted 15,000 restricted stock units
@ $0 |
|
| 01/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2019 |
4
| Barrett Elizabeth A. (CEO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 277,432 options to buy
@ $47.57, valued at
$13.2M
Granted 317,065 restricted stock units
@ $0 |
|
| 01/09/2019 |
3
| Barrett Elizabeth A. (CEO) has filed a Form 3 on UroGen Pharma Ltd. |
|
|